Gamma knife radiosurgery (GKRS) for pineal region tumors: a study of 147 cases by Wentao Li et al.
RESEARCH Open Access
Gamma knife radiosurgery (GKRS) for
pineal region tumors: a study of 147 cases
Wentao Li1†, Binfei Zhang2, Wenxing Kang3†, Boning Dong4†, Xudong Ma1, Jinning Song1*, Yonghong Liu5
and Zhenqiang Liang6
Abstract
Background: The purpose of this study is to evaluate the effectiveness of gamma knife radiosurgery (GKRS) in the
treatment of pineal region tumors (PRTs).
Methods: We retrospectively reviewed 147 cases of PRTs primarily treated with GKRS at our hospital between 1999
and 2009. Mean follow-up time was 67 months (range 60.5–100.1). The local tumor control rates (LTCRs) and overall
survival rates were calculated to evaluate the results of the GKRS treatment.
Results: At 2 months after GKRS, tumor volume was significantly reduced in 91 cases (61.9 %). At 6 months,
average tumor volume was 4.2 cm3 as compared to 8.47 cm3 before GKRS. By 1 year after GKRS, the tumor
completely disappeared in 57 patients. Fourteen patients underwent second treatment, and one patient had third
treatment. The overall survival rates were 72.1 % at 3 years and 66.7 % at 5 years for all patients and 62.4 % at
3 years and 54.5 % at 5 years for germ cell tumors (GCTs). The LTCRs were 94.30 % at 3 years and 90.80 % at
5 years for all patients and 88.00 % at 3 years and 77.27 % at 5 years for GCTs.
Conclusions: GKRS is an effective and safe modality that can be widely used to PRTs as the primary therapy.
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Background
The pineal region tumors (PRTs) are a deep-seated,
heterogeneous group of mass lesions, which are derived
from cells located in or adjacent to the pineal gland.
PRTs are rare, which accounts for 0.5–1 % of all intra-
cranial tumors in the United States and Europe [1] but
have a higher incidence of 3.2 % in Japan [2, 3], 0.9 % in
Islamabad [4], 1.2 % in Karachi [5], and 1.9 % in China
[6]. These tumors are approximately ten times more
common in children than in adults and constitute 3–8 %
of pediatric intracranial tumors [7].
Due to heterogeneous cellular origins, PRTs represent a
spectrum of neoplasms ranging from benign (teratoma,
meningioma, pineocytoma, ependymoma, etc.) to malig-
nant (pineoblastoma, malignant teratoma, malignant germ
cell tumors, etc.). The management strategies for these
tumors remain controversial [8]. Some investigators state
that surgical resection should be used as the initial thera-
peutic modality [9–11] and that histologic diagnosis of
PRTs is required for rational treatment. In contrast, some
Asian investigators [12] recommend a test dose of radi-
ation therapy based on the high incidence of germinoma
in their countries. There are regional differences in the
incidence of GCTs in the pineal region. In Asian, germ
cell tumors (GCTs) are more common overall (accounting
for 3/1 % of all primary brain tumors in Japan [13]/China,
respectively [6]) but are predominantly the more benign
germinomas. In Japan, GCTs account for 70.3 % of pineal
region tumors [6, 13]. Some experts in Japan advocate
empiric radiosurgery [14, 15] for reducing the cost of
treatment and the need for hospitalization. Several clinical
studies have demonstrated that gamma knife radiosurgery
(GKRS) has high efficacy and low morbidity [16], and thus
has the potential as a primary treatment modality [17, 18].
On the whole, GKRS is safe and effective for pineal
region tumors. The most successful GKRS treatment of
pineal region tumors has been with benign or low-grade
* Correspondence: jinningsong@126.com
Wentao Li, Wenxing Kang, and Boning Dong are co-first authors.
†Equal contributors
1Department of Neurosurgery, the First Affiliated Hospital, Medical School of
Xi’an Jiaotong University, #277, Yantaxi Rd, Xi’an 710061, China
Full list of author information is available at the end of the article
WORLD JOURNAL OF 
SURGICAL ONCOLOGY
© 2015 Li et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International
License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any
medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Li et al. World Journal of Surgical Oncology  (2015) 13:304 
DOI 10.1186/s12957-015-0720-5
lesions. The three broad categories of tumor treated by
GKRS include pineal parenchymal tumors (pineocyto-
mas and pineoblastomas), GCTs (germinomatous and
nongerminomatous), and glial tumors (astrocytomas).-
Pure germinomas are exquisitely radiosensitive. Many
studies [11, 18–20] mainly used GKRS as an adjuvant
therapy rather than as a primary treatment modality.
Only a few studies explore the efficacy of GKRS in treating
pineal region tumors in series as a primary method, and the
numbers of cases were small [19–21]. There is a need for
larger studies with longer follow-up before GKRS becomes
widely adopted in the treatment of pineal region tumors. In
this report, we reviewed our institutional experiences of
treating pineal region tumors by GKRS in 147 patients.
Methods
Ethics, consent, and permissions
This study was approved by the First Affiliated Hospital
of Xi' an Jiaotong University Institutional Review Board
and met the requirements of medical ethics. Consents to
participate the study from the participants (or legal par-
ent or guardian for children) were obtained.
Consent to publish
We had obtained consent to publish from the participants
(or legal parent or guardian for children) to report individ-
ual patients’ data in any form (including images, videos,
voice recordings, etc.).
Patient population and diagnosis
We retrospectively reviewed 147 consecutive cases of
pineal region tumors treated with GKRS at the First
Affiliated Hospital of Xi’an Jiaotong University (Xi’an,
China) between 1999 and 2009. All subjects were Han
Chinese from Northwest China. Inclusion criterion is: all
patients were newly diagnosed incident PRT cases under-
going GKRS at our institution. Exclusion criterion: patients
with arteriovenous malformations and brain metastases.
Diagnosis was mainly based on magnetic resonance im-
aging (MRI; GE HDxt 3.0T, USA) combined with medical
history, clinical presentations, Karnofsky performance
score [22], and patient age. T1-weighted and T2-weighted
MRI were performed. MRI scans were assessed independ-
ently by two radiologists blinded to the clinical outcome.
GKRS technique
Based on data from computer tomography (CT) and MRI,
patients of progressive hydrocephalus underwent ven-
tricular peritoneal (VP) shunt 7 days before GKRS (Elekta
Instruments, Atlanta, GA, USA). The Leksell GammaPlan
treatment planning software (versions 4.10–5.34, Elekta,
Sweden) was used on all patients. Between 1 and 9
isocenters (mean 6.24 isocenters) were used in treatment
planning. The Automated Positioning System (Elekta) was
used to streamline patient positioning. Central dose was
25–40 Gy (mean ± SD 36.34 ± 2.11 Gy), and marginal dose
was 9–15 Gy (mean ± SD 13.6 ± 1.02 Gy).
Patient assessment and follow-up
The duration of follow-up ranged from 60.5 to
100.1 months (mean 67 months). The results of GKRS
were mainly evaluated by changes in tumor size on MRI
at 1, 3, 6, and 12 months after GKRS. Meanwhile, the
neurological presentations were evaluated. The systemic
criteria proposed by the Japan Brain Tumor Registry
[23] were used. This system is composed of five grades
including complete response (CR; tumor disappearance),
partial response (PR; ≥50 % tumor volume reduction),
minor response (MR; 25–50 % reduction), no change
(NC; <25 % reduction), and progression (tumor enlarge-
ment). The local tumor control rate was calculated as
(CR + PR + MR + NC)/total.
Results
Patients’ characteristics
We identified 158 lesions in the 147 patients included in
this study. Eight patients had multiple lesions. Most
lesions were located in the pineal region. The demogra-
phics/clinical presentation of patients are summarized in
Table 1. There were 105 males and 42 females, with a ratio
of 2.5:1. Patients’ ages ranged from 6 to 74 years (mean ±
SD 35.6 ± 12.1 years). The mean volume of PRTs before
GKRS treatment was 8.47 cm3 (SD 6.22 cm3). The
duration between the onset of symptoms and admission at
our institute ranged from 3 months to 2 years. The most
Table 1 Clinical presentations of patients with germ cell tumors
(GCTs) and non-germ cell tumors (non-GCTs)
Classification Non-GCTs GCTs
No. of cases 107 40
Age 42.3 ± 10.2 14.4 ± 6.1
Minimum age 17 6






Nausea and vomiting 40 29
Polydipsia and polyuria 9 32
Eye movement disorders 23 18
Parinaud sindromas 16 19
Precocious puberty 2 1
Hypogenesis 1 4
Ataxia 15 12
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common symptoms were headache, nausea, and vomiting.
Other symptoms included polydipsia, polyuria, ataxia, eye
movement disorders, parinaud syndromes, precocious
puberty, and hypogenesis.
GKRS treatment
Patients first underwent MRI assessment to locate brain
tumors. The average Karnofsky score was 72.23. A total
of 104 (66 %) lesions occurred in adults and 54 (34 %)
occurred in children. The lesions showed clear boundary.
Some lesions had cystic changes, and gadodiamide-
enhanced (OmniScan, GE Healthcare) MRI showed uni-
form enhance mentor partial enhancement in cystic areas.
Eight patients had multiple lesions located in the pineal
region, parietal lobe, and occipital lobe. Forty patients
were diagnosed as germ cell tumors. The mean tumor
volume was 8.47 cm3 (0.1–29.2 cm3), and the maximum
tumor diameter was 3.8 cm. Dosimetry of GKRS is listed
in Table 2.
Follow-up
After GKRS treatment, three patients developed complica-
tions including severe headache, projectile vomiting and
subsequent coma and were transferred to the intensive
care unit. These patients were mainly given life-sustaining
treatment and treatment to reduce intracranial pressure.
One patient developed acute brain herniation due to
rapidly progressing severe brain edema and died. The
other two patients regained consciousness after their brain
edema disappeared and were transferred to a general
ward. They did not experience any other discomfort
during the follow-up period after leaving the hospital.
Fatigue was seen in 103 patients, headache in 97 patients,
and nausea and vomiting in 69 patients. After reducing
intracranial pressure using mannitol, these symptoms
were alleviated and gradually disappeared.
At 2 months after GKRS, lesions in 91 cases (61.9 %)
were significantly reduced, and symptoms were improved
or disappeared in 121 cases (83.31 %). At 6 months, radio-
graphic review showed that the average tumor volume
was reduced to 4.2 cm3 (range 0–19.7 cm3) from 8.47 cm3
before GKRS. The pineal region tumor volume was
reduced, and saddle or occipital lesions disappeared in
123 cases (83.67 %). Tumors in 17 cases increased in size,
but tumor density was reduced in 14 of these cases. The
average follow-up duration was 67.2 months (range 60.5–
100.1). The tumor disappeared in 57 patients after 1 year
(Table 3). The overall survival rates for 1, 3, and 5 years
after GKRS were 80.2, 72.1, and 66.7 %, respectively. Local
tumor control rates were 97.40, 94.30, and 90.80 %
for 1, 3, and 5 years, respectively.
We also analyzed the GCT cases separately. In the
GCT sub-group (40 cases), symptoms were improved in
13 cases and completely disappeared in 24 cases at
2 months post GKRS. At 6 months, lesions disappeared
in eight cases according to MRI scans. Another 8 cases
showed residual lesions and underwent second radiosur-
gery. There was no death for the 40 cases of GCTs. The
1-, 3-, and 5-year overall survival rates for GCTs
(Table 4) were 77.5, 62.4, and 54.5 %, respectively. The
local tumor control rates were 96.70, 88.00, and 77.27 %,
for 1, 3, and 5 years, respectively.
Fourteen patients in this study (eight of GCTs and six
of non-GCTs) underwent second treatment, and one of
these patients had third treatment. Eight of these
patients had multiple lesions that are either GCTs or
had a total volume of 21.5–28.1 cm3. One patient had
polyuria during the first 3 months after treatment. The
patients’ MRI revealed a new lesion in suprasellar region
oppressing pituitary stalk. Since the volume of pineal
region lesion did not reduce, this patient was given low
dose of whole brain radiation therapy. Five months later,
polyuria and the lesion in suprasellar region disappeared,
and pineal region tumor shrank.
Discussion
In this study, we reviewed the results of GKRS in 147 pa-
tients. The average duration of follow-up was 67.2 months.
The 3/5-year survival rates for patients after GKRS
treatment were 72.1/66.7 % for all patients and 62.4/
54.5 % for GCTs. The 3/5-year local tumor control rates
were 94.30/90.80 % for all patients and 88.00/77.27 % for
GCTs, respectively.
The results indicate that GKRS without histological
verification of PRTs is acceptable. It has been controversial
whether histological diagnosis before treatment is neces-
sary [10, 18, 24] in the management of PRTs, partly owing
to racial differences in incidence [1–3, 6]. Therefore, it is
not clear which treatment options are most beneficial.
With the advances of clinical image (MRI) and clinical
features, we can now diagnose PRTs and differentiate
GCTs from non-GCTs without histological analysis.
Therefore, GKRS can be performed either as a primary
therapy or as an adjuvant therapy for conventional
treatments. Kanamori [24] reported that the histological
diagnoses of 38 out of 39 GCT patients and all of eight
non-GCT patients were similar to their clinical diagnoses.
Konovalov reported that [10] surgery or GKRS for
Table 2 Dosimetry of GKRS
Items Mean ± SD
Tumor volume (cm3) 8.47 ± 6.22
No. of isocenters 6.24 ± 1.11
Central dose (Gy) 36.34 ± 2.11
Marginal dose (Gy) 13.6 ± 1.02
Maximum dose (Gy) 28.35 ± 5.37
GKRS Gamma knife radiosurgery, SD standard deviation
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patients with butterfly-shaped radiologic sign in MRI were
successful without pathologic confirmation of diagnosis.
Our institutional experiences support this option.
In our study, the 5-year survival rate for patients with
PRTs is 66.7 %; however, the survival rate in Kanamori’s
study [24] was 94 % without histological verification.
The difference in survival rate could be due in part to
the fact that there was no neoadjuvant chemotherapy in
our study. Alternatively, it could be due to differences in
the number of cases (147 cases in our study and 39 cases
in Kanamori’s) or patient population. The 5-year local
tumor control rate in our study was 90.80 %, which is
higher than 70 % in an earlier study of 49 cases [20]. In
the present study, the 1-, 3-, and 5-year overall survival
rates were 77.5, 62.4, and 54.5 %, respectively, in GCTs
cases (40 cases) after GKRS. Mori reported that [20] sur-
vival rates at 5 and 10 years after GKRS in GCT cases
(n = 38) were both 68 %. The difference in survival rate
could be due in part to diagnosis. In 13 of 38 patients
was histologically diagnosed, but in others GCT was
diagnosed by elevation of serum tumor markers or clin-
ical course. In our study, GCT was diagnosed by MRI,
medical history, and clinical presentations.
A definitive histological verification is surely desirable,
but successful treatment methods without the need for
biopsy have been developed [24, 25]. It is interesting that
the survival rates are not significantly influenced by the
unclear histological diagnosis. This phenomenon likely
results from the large variety of tumor types in the pineal
region running necessary biopsies in some circumstances.
With the development of neurosurgery and the emer-
gence of CT, MRI, and surgical microscope, it is possible
to achieve complete removal and secondary complete re-
moval. Therefore, there has been a significant decrease
in death rate. Microsurgical mortality is under 8 % and
disability rate is under 12 % [26]. Radiotherapy is safe and
effective, which makes it a good alternative treatment,
especially for germ cell tumors that are sensitive to radi-
ation. There are still disagreements over the treatment of
pinealoma. Considering the efficacy, imbalance of domes-
tic economic development, as well as cost-effectiveness of
surgical total resection and subtotal resection in develop-
ing countries [27], it is difficult to achieve a wide range of
application for surgical total resection and subtotal resec-
tion. As such, radiosurgery cannot be replaced by surgery
because it is a non-time-consuming, economic, and less
invasive therapy.
GKRS can not only kill the tumor cells but also reduce
the damage to the surrounding normal brain tissues
[28], thanks to its technical characteristic of large dose
in targeted area and low dose on the edge [29]. There-
fore, GKRS is associated with less systemic side effects
compared to conventional radiation. Moreover, it can also
be used to treat tumors that are insensitive to conven-
tional radiotherapy.
Pinealoma is usually accompanied by obstructive
hydrocephalus. Sixteen patients (10.9 %) in this study
had Parinaud’s syndrome, which is a sign of acute
obstructive hydrocephalus. In order to prevent peri-
operative and postoperative intracranial hypertension,
VP shunt was performed on patients with progressive
hydrocephalus. In the present study, patients treated
with mannitol after surgery had no intracranial hyper-
tension, infection, or shunt malfunction. These findings
indicate that we can improve the safety of GKRS by ac-
tively dealing with hydrocephalus.
Given that pinealoma may metastasize by seeding
through the cerebrospinal fluid pathways, there is a
Table 3 Evaluation of all (147) cases after GKRS treatment
CR (%) PR (%) MR (%) NC (%) PROGR (%) Total LTCR (%) ATV (cm3) Karnofsky scoring Survival rate (%)
Before treatment 8.47 72.23
1 year after treatment 57 (48.31) 34 (28.81) 22 (18.64) 2 (1.69) 3 (2.54) 118 97.40 1.23 87.83 ± 7.31 80.2
3 years after treatment 52 (49.06) 27 (25.41) 19 (17.92) 2 (1.89) 6 (5.66) 106 94.30 1.33 77.25 ± 13.38 72.1
5 years after treatment 43 (43.88) 26 (26.53) 17 (17.35) 3 (3.06) 9 (9.18) 98 90.80 2.29 76.43 ± 17.76 66.7
Abbreviations: GKRS Gamma knife radiosurgery, CR complete response (tumor disappearance), PR partial response (≥50 % tumor volume reduction), MR minor
response (25–50 % reduction), NC no change (<25 % reduction), PROGR progression (tumor enlargement), LTCR local tumor control rate = CR + PR + MR + NC/total,
ATV average tumor volume
Table 4 Evaluation of GCTs (40 cases) after GKRS treatment
CR (%) PR (%) MR (%) NC (%) PROGR (%) Total number LTCR (%) ATV (cm3) Karnofsky scoring Survival rate (%)
Before treatment 7.28 76.25
1 year after treatment 14 (45.16) 12 (38.71) 2 (6.45) 2 (6.45) 1 (3.23) 31 96.70 2.21 85.22 ± 9.15 77.5
3 years after treatment 11 (44.00) 8 (32.00) 1 (4.00) 2 (8.00) 3 (12.00) 25 88.00 2.54 72.52 ± 14.58 62.4
5 years after treatment 8 (36.36) 7 (31.82) 1 (4.55) 1 (4.55) 5 (22.73) 22 77.27 2.91 66.14 ± 16.86 54.5
Abbreviations: GCTs germ cell tumors, GKRS gamma knife radiosurgery, CR complete response (tumor disappearance), PR partial response (≥50 % tumor volume
reduction), MR minor response (25–50 % reduction), NC no change (<25 % reduction), PROGR progression (tumor enlargement), LTCR local tumor control
rate = CR + PR + MR + NC/total, ATV average tumor volume
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debate about whether radiotherapy or chemotherapy
should be used. The rate of metastases from pinealoma
is continually rising based on recent reports. Ogawa et
al. [30] reviewed 126 cases of intracranial germ cell tu-
mors that underwent full central radiotherapy and found
that the incidence of spinal relapses was 4 % (2 of 56) for
patients treated with spinal irradiation and 3 % (2 of 70)
for those without spinal irradiation. Nguyen et al. [31]
reviewed 21 patients with intracranial germinoma treated
with radiotherapy and found that irradiation with chemo-
therapy is associated with increased rates of failures in the
brain and spine.
Conclusion
In conclusion, our institutional experiences support that
GCTs may be diagnosed based on MRI and clinical
presentations without biopsy or surgery. Moreover,
GKRS appears to be an effective, low-risk treatment
option that can be widely used for pineal region tumors
either as a primary therapy without histological diagnosis.
Further studies are needed to evaluate the effectiveness of
GKRS for the treatment of PRTs as a primary therapy in
more details.
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